# Prospective, Non-interventional Study Assessing Periorbital Rejuvenation Procedure

> **NCT07398755** · — · COMPLETED · sponsor: **Yuvell** · enrollment: 29 (actual)

## Conditions studied

- Glabellar Lines
- Midface Volume Deficiency
- Periorbital Wrinkling

## Interventions

- **DRUG:** Letybo®
- **DEVICE:** Philart® Eye
- **DEVICE:** Saypha® Volume Plus Lidocaine

## Key facts

- **NCT ID:** NCT07398755
- **Lead sponsor:** Yuvell
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-02
- **Primary completion:** 2025-12-11
- **Final completion:** 2026-03-11
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07398755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07398755, "Prospective, Non-interventional Study Assessing Periorbital Rejuvenation Procedure". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07398755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*